• According to Transparency Market Research’s latest report on the global inhalation and nasal spray generic drugs market for the historical period 2017–2018 and forecast period 2019–2027, increasing prevalence of asthma and COPD disorders, and burgeoning demand for cost-effective generic drugs are projected to drive the global inhalation and nasal spray generic drugs market during the forecast period
  • According to the report, the global inhalation and nasal spray generic drugs market was valued at US$ 27.5 Bn in 2018 and is anticipated to expand at a CAGR of 4.80% from 2019 to 2027
fa global inhalation nasal spray generic drugs marke

To know the scope of our report Get a Sample on Inhalation and Nasal Spray Generic Drugs Market

Rising prevalence of asthma and COPD Disorders: Key Drivers

  • Asthma and chronic obstructive pulmonary disease (COPD) are considered serious health problems. These affect a large proportion of the global population. Smoking, tobacco use, and air pollution are few of the risk factors associated with asthma and COPD. According to the American Lung Association, smoking is the primary risk factor for COPD and approximately 80% of COPD-related deaths are caused by smoking.
  • According to Global Burden of Disease Study 2015, asthma and COPD were the most prevalent chronic respiratory disease, affecting over 360 and 175 million people in 2015, respectively.
  • Prevalence of asthma and COPD is increasing in developed countries due to modernized lifestyle. On the other hand, air pollution and high rate of smoking have led to higher prevalence of serious respiratory diseases in developing countries.
  • Increase in the geriatric population suffering from COPD and asthma is also expected to accelerate the growth of the inhalation and nasal spray generic drugs market

Get a glimpse of the in-depth analysis through our Report Brochure
 

Stringent Regulations for Generic Drugs to Hamper Market

  • With the availability of growing number of low-cost generic inhalation and nasal spray drugs across the globe, various regulatory bodies have opted for stringent norms in order to focus on quality. Regulators in developing regions such as Brazil, Mexico, and Russia have changed their regulatory guidelines pertaining to the sale of generic drugs. This change in regulation norms has led to considerable delays in approval processes, thereby launch of generic drugs in these markets
  • Furthermore, the new regulatory laws in Russia mandate clinical trials for generic products as well, thereby creating hurdles for various pharmaceutical companies operating in the region. Similarly, the Drugs Controller General of India, a domestic drug regulatory body, constituted several new drug advisory committees to oversee and check clinical trials, new drug approval processes, etc.
  • Therefore, stringent and strict regulatory norms put up by various developing countries would lead to sluggish growth of the inhalation and nasal spray generic drugs market.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Inhalation and nasal spray generic drugs Market: Competitive Landscape

  • This report profiles major players in the global inhalation and nasal spray generic drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global inhalation and nasal spray generic drugs market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global inhalation and nasal spray generic drugs market are
    • Allergan plc
    • Beximco Pharmaceuticals Ltd
    • Cipla Limited
    • Mylan N.V.
    • Nephron Pharmaceuticals Corporation
    • Sun Pharmaceutical Industries Ltd.
    • Hikma Pharmaceuticals PLC
    • Sandoz International GmbH (a Novartis Division)
    • Perrigo Company plc
    • Catalent Pharma Solutions
    • Teva Pharmaceutical Industries Ltd.

Global Inhalation and nasal spray generic drugs Market: Key Developments

Key players in the global inhalation and nasal spray generic drugs market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global inhalation and nasal spray generic drugs market. A few expansion strategies adopted by players operating in the global inhalation and nasal spray generic drugs market are:

  • In February 2020, Perrigo Company and Catalent Pharma Solutions announced the attainment of abbreviated new drug application (ANDA) approval from the U.S. FDA for the generic version of ProAir HFA. ProAir HFA is a medication for the treatment and prevention of reversible obstructive airway disease, and bronchospasm. 
  • In July 2015, Hikma Pharmaceuticals acquired Roxane Laboratories Inc. and Boehringer Ingelheim Roxane Inc., from Boehringer Ingelheim. Roxane was one of the leading U.S. specialty generics company. This acquisition enabled Hikma to strengthen its position in the U.S. generics market.

The report on the global inhalation and nasal spray generic drugs market discussed individual strategies, followed by company profiles of manufacturers of inhalation and nasal spray generic drugs. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global inhalation and nasal spray generic drugs market.

TMR’s report on the global Inhalation & Nasal Spray Generic Drugs market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global Inhalation & Nasal Spray Generic Drugs market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Inhalation & Nasal Spray Generic Drugs market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global Inhalation & Nasal Spray Generic Drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global Inhalation & Nasal Spray Generic Drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global Inhalation & Nasal Spray Generic Drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global Inhalation & Nasal Spray Generic Drugs market.

The report delves into the competitive landscape of the global Inhalation & Nasal Spray Generic Drugs market. Key players operating in the global Inhalation & Nasal Spray Generic Drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Inhalation & Nasal Spray Generic Drugs market that have been profiled in this report.

Key Questions Answered in Global Inhalation & Nasal Spray Generic Drugs Market Report

  • What is the scope of growth of product companies in the global Inhalation & Nasal Spray Generic Drugs market?
  • What will be the Y-o-Y growth of the global Inhalation & Nasal Spray Generic Drugs market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global Inhalation & Nasal Spray Generic Drugs market?
  • Will North America continue to be the most profitable market for Inhalation & Nasal Spray Generic Drugs providers?
  • Which factors are anticipated to hamper the growth of the global Inhalation & Nasal Spray Generic Drugs market during the forecast period?
  • Which are the leading companies in the global Inhalation & Nasal Spray Generic Drugs market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global Inhalation & Nasal Spray Generic Drugs market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global Inhalation & Nasal Spray Generic Drugs market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the Inhalation & Nasal Spray Generic Drugs market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the Inhalation & Nasal Spray Generic Drugs market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global Inhalation & Nasal Spray Generic Drugs market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global Inhalation & Nasal Spray Generic Drugs market more reliably and accurately.

Regional Segmentation of Inhalation & Nasal Spray Generic Drugs Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Global Inhalation & Nasal Spray Generic Drugs Market - Segmentation

Drug Class

Corticosteroids

  • Fluticasone
  • Budesonide
  • Beclomethasone
  • Flunisolide
  • Others

Bronchodilators

  • Albuterol
  • Epinephrine
  • Others

Antihistamines

  • Combinations
  • Salmeterol/Fluticasone
  • Formoterol/Budesonide
  • Azelastine/Benzalkonium Chloride
  • Others

Decongestant Sprays

  • Phenylephrine Hydrochloride
  • Oxymetazoline Hydrochloride

Indication

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Allergic Rhinitis

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Inhalation Nasal Spray Generic Drugs

Buy Now